Related Experiment Videos
A comparison of contraceptive procurement pre- and post-benefit change
Debbie Postlethwaite1, James Trussell, Anthony Zoolakis
1Kaiser Permanente, Northern California, Women's Health Research Institute, Oakland, CA 94612, USA. debbie.a.postlethwaite@kp.org
Background:
In 2002, the Kaiser Foundation Health Plan in California changed its coverage policy to include 100% universal coverage for the most effective forms of contraception and for emergency contraceptive pills (ECPs). This study sought to evaluate whether removing the cost of contraception as a potential barrier to utilization would lead to a change in the mix of contraceptive methods prescribed and purchased by a large health plan and whether those changes could theoretically result in averting a greater number of unintended pregnancies.
Study Design:
A retrospective observational study was conducted to describe the mix of reversible contraceptives procured before and after the benefit change at Kaiser Permanente Northern California. We then estimated couple-years of protection (CYP) to examine whether the contraceptive mix changed to more effective reversible methods.
Results:
After the contraceptive benefit change, CYP increased by 28% (from 2001-2002 to 2003-2004), while the number of females aged 15-44 enrolled in this health plan fell by 1%. CYP for intrauterine contraceptives (IUCs) and injectables rose by 137% and 32%, respectively, while CYP for the pill, patch and ring rose only by 16%. The estimated average annual contraceptive failure rate among women using hormonal contraceptives and IUCs declined from 7.0% to 6.4%. Purchasing of the ECP rose by 88%.
Conclusion:
Removal of the cost of contraception may result in increased utilization of more effective methods and ECPs.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
The Placebo Effect
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence